Rockefeller Capital Management L.P. Buys 72,636 Shares of SPDR S&P Biotech ETF $XBI

Rockefeller Capital Management L.P. raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 44.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 236,057 shares of the exchange traded fund’s stock after acquiring an additional 72,636 shares during the period. Rockefeller Capital Management L.P. owned approximately 0.35% of SPDR S&P Biotech ETF worth $28,782,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Avoro Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $256,053,000. Wells Fargo & Company MN increased its position in shares of SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after acquiring an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp raised its holdings in SPDR S&P Biotech ETF by 42,425.2% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after acquiring an additional 1,187,907 shares during the last quarter. Morgan Stanley raised its holdings in SPDR S&P Biotech ETF by 8.3% in the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after acquiring an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. lifted its position in SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after acquiring an additional 635,782 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 3.7%

SPDR S&P Biotech ETF stock opened at $145.86 on Tuesday. The firm has a market cap of $9.31 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The stock has a fifty day simple moving average of $133.84 and a two-hundred day simple moving average of $127.95. SPDR S&P Biotech ETF has a 12 month low of $80.90 and a 12 month high of $146.77.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.